EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The impact of platelet-rich plasma in the short-term management of chronic discogenic pain: A randomized controlled trial

Vahid Tavakolian-Ferdousie, Reza Goujani, Alireza Farsinejad, Hanif Vosoughi, Mohsen Shahba

Journal of Emergency Practice and Trauma · 18.12.2025 · 10 (2) · 149-155

DOI: 10.34172/jept.2025.24 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Emergency Practice and Trauma, online erschienen am 18.11.2025. Verfasst von Vahid Tavakolian-Ferdousie und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Platelet-rich plasma (PRP), derived from the patient’s own blood and containing a high density of bioactive compounds, is an emerging therapeutic option for the management of spine-related disorders. This study aimed to evaluate the short-term efficacy of PRP therapy in managing chronic discogenic low back pain compared with conventional treatment.

Methods

In the present randomized controlled trial, 32 participants were enrolled from the Neurosurgery Ward at Shahid Bahonar Hospital in Kerman; all patients had a diagnosis of chronic discogenic low back pain. The subjects were randomly assigned to a PRP treatment group (n = 15) and a control group (n = 17). PRP was prepared using a standardized protocol and injected into the affected disc under fluoroscopic guidance. Control group participants underwent conventional treatment, specifically physical therapy and analgesics. Pain intensity (VAS), functional disability (ODI), analgesic use, and adverse events were monitored at baseline and at 1, 4, and 12 weeks, and at 6 months post-treatment.

Results

The PRP and control groups had mean ages of 47.5 ( ± 9.2) and 49.8 ( ± 8.8) years, respectively (P = 0.487). The PRP intervention resulted in significantly improved VAS scores as early as 1 week post-treatment, with improvements persisting at weeks 4 and 12 and at month 6 (P < 0.05). The PRP group showed greater reductions in ODI scores at both the 12-week and 6-month follow-ups (P < 0.05).

Conclusion

PRP therapy significantly alleviates pain and improves function in patients with low back pain. This makes it a promising alternative to conventional treatment approaches.

Zitieren

APA

Tavakolian-Ferdousie, V., Goujani, R., Farsinejad, A., Vosoughi, H., & Shahba, M. (2025). The impact of platelet-rich plasma in the short-term management of chronic discogenic pain: A randomized controlled trial. Journal of Emergency Practice and Trauma, 10(2), 149-155. https://doi.org/10.34172/jept.2025.24

Vancouver

Tavakolian-Ferdousie V, Goujani R, Farsinejad A, Vosoughi H, Shahba M. The impact of platelet-rich plasma in the short-term management of chronic discogenic pain: A randomized controlled trial. Journal of Emergency Practice and Trauma. 2025;10(2):149-155. doi:10.34172/jept.2025.24

BibTeX
@article{TavakolianFerdousie2025,
  author = {Tavakolian-Ferdousie, Vahid and Goujani, Reza and Farsinejad, Alireza and Vosoughi, Hanif and Shahba, Mohsen},
  title = {The impact of platelet-rich plasma in the short-term management of chronic discogenic pain: A randomized controlled trial},
  journal = {Journal of Emergency Practice and Trauma},
  year = {2025},
  volume = {10},
  number = {2},
  pages = {149--155},
  doi = {10.34172/jept.2025.24}
}
Kostenlos starten →